We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Alliance to Develop Molecular Diagnostics

By HospiMedica staff writers
Posted on 04 Jul 2002
A long-term strategic alliance to develop, manufacture, and market a broad range of in vitro molecular diagnostic products has been announced by Abbott Laboratories (Abbott Park, IL, USA) and Celera Diagnostics Group (Alameda, CA, USA), a joint venture between Abbott and Applied Biosystems Group (Foster City, CA, USA).

The alliance plans to develop and commercialize molecular diagnostic products for disease detection, monitoring, and therapy selection. More...
Diseases and chronic conditions to be targeted include cardiovascular and autoimmune diseases, central nervous system disorders, and cancer. Around 250 scientists and engineers from the two companies will initially be devoted to the program, which will encompass a large-scale discovery effort to identify new diagnostic markers. Celera will focus on genetic marker discovery, new marker validation, and assay development. Abbott will focus on product development, sales, and marketing. The two companies will share technologies, patents, profits, and expenditures.

"This will help accelerate our joint strategy to develop and market a broad menu of next-generation molecular diagnostic products focused on unmet diagnostic needs,” said Edward Michael, vice president, commercial operations, diagnostics, Abbott Laboratories.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Hematology Consumables
Bioblood Devices
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.